Skip to main content
. Author manuscript; available in PMC: 2008 Aug 10.
Published in final edited form as: Biochemistry. 2006 Sep 12;45(36):10973–10980. doi: 10.1021/bi061193r

Figure 9.

Figure 9

The effect of NBD-556 on viral entry. The effect of NBD-556 on the infection of Cf2Th-CCR5 cells by recombinant luciferase-expressing HIV-1 bearing the envelope glycoproteins of the YU2 strain of HIV-1 or the amphotropic murine leukemia virus (A-MLV) is shown. Virus infection is expressed as the percentage of infection (measured by luciferase activity in the target cells) observed in the presence of NBD-556 relative to the level of infection observed in the absence of drug.